Cyclacel Pharmaceuticals Inc (CYCC)
2.00
-0.48
(-19.35%)
USD |
NASDAQ |
May 03, 16:00
2.00
0.00 (0.00%)
After-Hours: 16:09
Cyclacel Pharmaceuticals Free Cash Flow: -16.12M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.12M |
| September 30, 2023 | -17.38M |
| June 30, 2023 | -20.31M |
| March 31, 2023 | -20.92M |
| December 31, 2022 | -20.83M |
| September 30, 2022 | -20.22M |
| June 30, 2022 | -19.47M |
| March 31, 2022 | -21.70M |
| December 31, 2021 | -18.57M |
| September 30, 2021 | -15.21M |
| June 30, 2021 | -11.17M |
| March 31, 2021 | -8.863M |
| December 31, 2020 | -8.03M |
| September 30, 2020 | -7.956M |
| June 30, 2020 | -7.792M |
| March 31, 2020 | -8.582M |
| December 31, 2019 | -9.457M |
| September 30, 2019 | -10.38M |
| June 30, 2019 | -9.089M |
| March 31, 2019 | -8.265M |
| December 31, 2018 | -6.74M |
| September 30, 2018 | -6.92M |
| June 30, 2018 | -7.453M |
| March 31, 2018 | -5.842M |
| December 31, 2017 | -7.493M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.214M |
| June 30, 2017 | -9.909M |
| March 31, 2017 | -10.74M |
| December 31, 2016 | -10.08M |
| September 30, 2016 | -9.814M |
| June 30, 2016 | -10.98M |
| March 31, 2016 | -12.73M |
| December 31, 2015 | -14.49M |
| September 30, 2015 | -15.49M |
| June 30, 2015 | -17.82M |
| March 31, 2015 | -19.17M |
| December 31, 2014 | -19.01M |
| September 30, 2014 | -20.82M |
| June 30, 2014 | -16.52M |
| March 31, 2014 | -17.70M |
| December 31, 2013 | -18.41M |
| September 30, 2013 | -15.38M |
| June 30, 2013 | -15.34M |
| March 31, 2013 | -13.74M |
| December 31, 2012 | -12.06M |
| September 30, 2012 | -12.86M |
| June 30, 2012 | -13.01M |
| March 31, 2012 | -13.87M |
| December 31, 2011 | -13.98M |
| September 30, 2011 | -14.47M |
Free Cash Flow Range, Past 5 Years
-21.70M
Minimum
Mar 2022
-7.792M
Maximum
Jun 2020
-14.32M
Average
-15.21M
Median
Sep 2021
Free Cash Flow Benchmarks
| Corvus Pharmaceuticals Inc | -23.97M |
| Oragenics Inc | -7.291M |
| Relmada Therapeutics Inc | -51.66M |
| Alpine Immune Sciences Inc | -79.50M |
| MAIA Biotechnology Inc | -13.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.91M |
| Cash from Financing (Quarterly) | 0.999M |
| Free Cash Flow Per Share (Quarterly) | -4.405 |
| Free Cash Flow to Equity (Quarterly) | -3.91M |
| Free Cash Flow to Firm (Quarterly) | -3.91M |
| Free Cash Flow Yield | -947.2% |